Skip to main content
Premium Trial:

Request an Annual Quote

BU and Fraunhofer to Develop Arrays for Dx Applications

NEW YORK (GenomeWeb News) — Boston University’s College of Engineering yesterday said it will partner with German biotech Fraunhofer to develop microarrays for molecular diagnostic applications.
When it begins in January, the so-called BU-Fraunhofer Alliance for Medical Devices, Instrumentation and Diagnostics will be a 5-year, $5-million jointly funded initiative that will work with the school’s Department of Biomedical Engineering.
Andrew Sharon, director of the Fraunhofer Center for Manufacturing and Innovation, said the alliance will create disposable chips for molecular-level disease diagnosis.
The firm will fabricate DNA and peptide arrays and perform translational research with the medical school, Sharon said. “We are trying to develop new devices and methods that will accelerate the process of moving research to the medical application.”
Munich-based Fraunhofer is involved in various hi-tech research fields and several biomedical areas, including medical imaging and array-based diagnostics.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.